Risultati della ricerca - Janku, Filip

Bringing target-matched PI3King from the bench to the clinic di Janku, Filip

Testo Testo Testo

Tumor heterogeneity in the clinic: is it a real problem? di Janku, Filip

Testo Testo Testo

Deciding site of biopsy at metastatic relapse: reply di Janku, Filip

Testo Testo Testo

Liquid Biopsies Using Plasma Exosomal Nucleic Acids di Möhrmann, Lino, Janku, Filip

Testo Testo Testo

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives di Bupathi, Manojkumar, Kaseb, Ahmed, Janku, Filip

Testo Testo Testo

Targeted Therapies for Advanced Ewing Sarcoma Family of Tumours di Jiang, Yunyun, Ludwig, Joseph, Janku, Filip

Testo Testo Testo

Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet? di Polivka, Jiri, Pesta, Martin, Janku, Filip

Testo Testo Testo

Successful Treatment of Castleman’s Disease with Interleukin-1 Receptor Antagonist (Anakinra) di El-Osta, Hazem, Janku, Filip, Kurzrock, Razelle

Testo Testo Testo

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening di Adashek, Jacob J., Janku, Filip, Kurzrock, Razelle

Testo Testo Testo

A Tale of Two Histiocytic Disorders di Janku, Filip, Munoz, Javier, Subbiah, Vivek, Kurzrock, Razelle

Testo Testo Testo

Castleman’s disease and sarcoidosis, a rare association resulting in a “mixed” response: a case report di Mohammed, Anwarullah, Janku, Filip, Qi, Ming, Kurzrock, Razelle

Testo Testo Testo

A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R): Implications for Inhibition of the IGF-1R signal di Janku, Filip, Huang, Helen J., Angelo, Laura S., Kurzrock, Razelle

Testo Testo

Bevacizumab-Based Treatment in Colorectal Cancer with a NRAS Q61K Mutation di Janku, Filip, Wheler, Jennifer J., Hong, David S., Kurzrock, Razelle

Testo Testo Testo

STAT3 Inhibitors: Finding a Home in Lymphoma and Leukemia di Munoz, Javier, Dhillon, Navjot, Janku, Filip, Watowich, Stephanie S., Hong, David S.

Testo Testo Testo

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing di Janku, Filip, Kaseb, Ahmed O., Tsimberidou, Apostolia M., Wolff, Robert A., Kurzrock, Razelle

Testo Testo

Non-Small Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment di Falchook, Gerald S., Janku, Filip, Tsao, Anne S., Bastida, Christel C., Stewart, David J., Kurzrock, Razelle

Testo Testo Testo

Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape di Subbiah, Ishwaria M., Tsimberidou, Apostolia, Subbiah, Vivek, Janku, Filip, Roy-Chowdhuri, Sinchita, Hong, David S.

Testo Testo Testo

A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma di Subbiah, Vivek, Brown, Robert E., McGuire, Mary F., Buryanek, Jamie, Janku, Filip, Younes, Anas, Hong, David

Testo Testo

Multiple gene aberrations and breast cancer: lessons from super-responders di Wheler, Jennifer J., Atkins, Johnique T., Janku, Filip, Moulder, Stacy L., Yelensky, Roman, Stephens, Philip J., Kurzrock, Razelle

Testo Testo Testo

Challenges and perspective of drug repurposing strategies in early phase clinical trials di Kato, Shumei, Moulder, Stacy L., Ueno, Naoto T., Wheler, Jennifer J., Meric-Bernstam, Funda, Kurzrock, Razelle, Janku, Filip

Testo Testo